ARCHIVES

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

This article is from The Cancer Letter archive.

Vol. 27 No. 27 | July 6, 2001

Download PDF Visit The Full Archive

Related Articles

Duke Halts Third Trial; Coauthor Disputes Claim That Data Validation Was Blinded

October 23, 2009

Cooperative Groups Fight to Keep CGOP Alive As DCPC, DCT Argue Over Who Pays

July 11, 1986

Delayed Prostate Cancer Surgery Poses No Increased Risk For Some Patients

February 24, 2006

DCT Board Approves $8 Million In Contract Projects For Recompetition

October 31, 1980

NAB Approves Subcommittee Recommendations On Organ Site Program – NIH Review, One Headquarters

May 21, 1982

‘Rush To Downsize’ Is A Danger To NCI, Broder Warns In A Farewell Address

January 13, 1995